RE:gatesGates2000000 wrote: exrof volume is too low for today news . its time to move on the nasdaq
Can't say I agree entirely with Gates on that one.
An uplisting at the Nasdaq doesn't come without drawbacks.
It isn't cheap, and as well as membership fees it incurs additional administrative costs in order to remain compliant with more stringent reporting requirements.
Besides, the volumes are quite acceptable already, the stock traded 261k shares in the US today.
Any relative illiquidity in the US would actually be advantageous to existing shareholders if the company suddenly became a focus of attention there.
Uplisting certainly hasn't done Pyrogenesis any good, and it sure as hell didn't do Xebec any good.
If it isn't broken, why fix it sort of thing